Rethinking Clinical Trials with Synthetic Control Arms 25 Apr Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous Verinnogen raises £500k to advance cancer drug development Next Next Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models
Rethinking Clinical Trials with Synthetic Control Arms 25 Apr Written by Alexandra Collingbourne Alexandra Collingbourne
